Risk Factors for Onset and Persistence of TMD
Risk Factors for Onset and Persistence of TMD
批准号:
7487496
负责人:
WILLIAM MAIXNER
金额:
$263.6万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-15 至 2012-07-31
关键词:
AddressAgeAnxietyArthralgiaBehavior TherapyBiologicalBiological ProcessBlood PressureCandidate Disease GeneCaringCase-Control StudiesCaucasoid RaceCharacteristicsChronicClinicalClinical PathwaysCohort StudiesCollaborationsConditionCraniofacial PainDataData Coordinating CenterDevelopmentDrug FormulationsEnrollmentEpidemiologic StudiesEpidemiologistEtiologyEuropeanEventFemaleFunctional disorderGenetic VariationGoalsHeadacheIn VitroIncidenceIncidence StudyIndividualInstitutesInstitutionJointsLifeLife StressMeasuresMental DepressionModelingNumbersObservational StudyOnset of illnessOutcomePainPain DisorderPain MeasurementParticipantPathogenesisPatientsPhysiologicalPopulationProceduresProspective StudiesPsychological FactorsPublishingRangeRateRecording of previous eventsRecruitment ActivityResearchResearch DesignResearch PersonnelRestRiskRisk FactorsSiteSpecific qualifier valueStimulusTemporomandibular Joint DisordersThinkingTimeWomanbasebiopsychosocialchronic paincohortdesigndisorder riskfollow-upgenetic risk factorgenetic variantin vivoinsightnovelprogramsprospectivepsychologicpsychosocialracial and ethnicresearch studysex
中文摘要
描述(由申请人提供):TMD发作和持续的风险因素:肌源性颞下颌关节紊乱病(TMD),伴或不伴关节痛,在美国人群中仅次于头痛,是最可能导致颅面疼痛和功能障碍的临床疾病。在过去的十年中,少数流行病学研究试图量化的发病率TMD的欧洲遗产的人口,但是,迄今为止,没有调查小组进行了大规模的,假设驱动的,前瞻性的研究,旨在确定生物心理社会和遗传危险因素的发病和持续性的这种令人烦恼的疼痛障碍。我们建议与国际公认的流行病学家、疼痛研究人员和遗传学家合作,对TMD的发病率进行一项全面的前瞻性队列研究。参与者将在四个研究机构和我们的数据协调中心(巴特尔纪念研究所)进行招募和前瞻性随访。我们的三个目标是:a)对从四个研究地点的主要种族和种族阶层招募的3200名最初无TMD的个体进行为期五年的前瞻性队列研究,量化首发TMD的发病率; B)通过招募200名在队列招募期间确定的患有慢性症状的TMD的人进行病例对照研究,这些人的TMD病史将他们排除在前瞻性研究之外; c)使用我们根据自己的研究和其他已发表的研究开发的TMD概念性因果模型,在两组中确定TMD风险预测因子的个体和联合效应。我们的初步流行病学研究结果导致了一个中心假设,即疼痛放大和心理因素,这两者都受到遗传变异的影响,代表了影响TMD发病和持续性的因果风险因素。我们建议的研究结果将确定主要的社会人口统计学,临床,生物,心理和遗传的风险因素,TMD的发病和持续性。通过这样做,我们将获得有关TMD发病机制的重要和新颖的信息,这将有助于发展基于证据的TMD药理学和行为干预措施。
英文摘要
DESCRIPTION (provided by applicant): Risk factors for onset and persistence of TMD: Myogenous temporomandibular disorder (TMD), with or without arthralgia, ranks second only to headache as the clinical condition most likely to cause craniofacial pain and dysfunction in the U.S. population. During the last decade, a small number of epidemiological studies have attempted to quantify the incidence of TMD in populations of European heritage; however, no investigative team to date has undertaken a large-scale, hypothesis-driven, prospective study designed to identify biopsychosocial and genetic risk factors for the onset and persistence of this vexing pain disorder. We propose to conduct a comprehensive, prospective cohort study of the incidence of TMD in collaboration with an internationally recognized group of epidemiologists, pain researchers, and geneticists. Participants will be enrolled and followed prospectively at four research institutions and by our Data Coordinating Center (Battelle Memorial Institute). Our three goals are to: a) undertake a five-year, prospective cohort study of 3200 initially TMD-free individuals recruited from major ethnic and racial strata at four study sites, quantifying incidence rates of first-onset-TMD; b) undertake a case-control study by recruiting 200 people with chronically symptomatic TMD identified during cohort recruitment whose history of TMD precludes them from the prospective study; c) to identify in both groups the individual and joint effects of predictors of TMD risk using a conceptual, causal model for TMD that we have developed based our own studies and other published research. Our preliminary epidemiological findings have led to the central hypothesis that pain amplification and psychological factors, both of which are influenced by genetic variants, represent causal risk factors that influence TMD onset and persistence. The outcomes of our proposed study will identify the primary socio-demographic, clinical, biological, psychological, and genetic risk factors for TMD onset and persistence. In so doing, we will obtain important and novel information regarding the etiopathogenesis of TMD, which will assist with the development of evidenced based pharmacological and behavioral interventions for TMD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Behavioral Core
-
批准号:9703531
-
项目类别:
-
资助金额:$27.35万
-
财政年份:2020
-
负责人:WILLIAM MAIXNER
-
依托单位:
Administrative Core
-
批准号:9703530
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2020
-
负责人:WILLIAM MAIXNER
-
依托单位:
Role of Preoperative Baroreflex Sensitivity on Postoperative and Persistent Pain after Thoracic Surgery
-
批准号:9809527
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2019
-
负责人:WILLIAM MAIXNER
-
依托单位:
SCREENING FOR UNC NEUROSENSORY DISORDERS PROJECTS
-
批准号:7716815
-
项目类别:
-
资助金额:$2.07万
-
财政年份:2008
-
负责人:WILLIAM MAIXNER
-
依托单位:
SCREENING FOR UNC NEUROSENSORY DISORDERS PROJECTS
-
批准号:7625605
-
项目类别:
-
资助金额:$9.04万
-
财政年份:2006
-
负责人:WILLIAM MAIXNER
-
依托单位:
Risk Factors for Onset and Persistence of TMD
-
批准号:8069416
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2005
-
负责人:WILLIAM MAIXNER
-
依托单位:
Risk Factors for Onset and Persistence of TMD
-
批准号:8138804
-
项目类别:
-
资助金额:$60.67万
-
财政年份:2005
-
负责人:WILLIAM MAIXNER
-
依托单位:
Risk Factors for Onset and Persistence of TMD
-
批准号:7900028
-
项目类别:
-
资助金额:$255.26万
-
财政年份:2005
-
负责人:WILLIAM MAIXNER
-
依托单位:
Risk Factors for Onset and Persistence of TMD
-
批准号:8112597
-
项目类别:
-
资助金额:$244.45万
-
财政年份:2005
-
负责人:WILLIAM MAIXNER
-
依托单位:
Risk Factors for Onset and Persistence of TMD
-
批准号:7261980
-
项目类别:
-
资助金额:$257.59万
-
财政年份:2005
-
负责人:WILLIAM MAIXNER
-
依托单位:
Risk Factors for Onset and Persistence of TMD
-
批准号:6984592
-
项目类别:
-
资助金额:$249.71万
-
财政年份:2005
-
负责人:WILLIAM MAIXNER
-
依托单位:
Risk Factors for Onset and Persistence of TMD
-
批准号:7123028
-
项目类别:
-
资助金额:$259.25万
-
财政年份:2005
-
负责人:WILLIAM MAIXNER
-
依托单位:
Risk Factors for Onset and Persistence of TMD
-
批准号:7664587
-
项目类别:
-
资助金额:$255.47万
-
财政年份:2005
-
负责人:WILLIAM MAIXNER
-
依托单位:
Administrative Core
-
批准号:6877000
-
项目类别:
-
资助金额:$5.29万
-
财政年份:2004
-
负责人:WILLIAM MAIXNER
-
依托单位:
Complex Persistant Pain Conditions: Unique & Shared Pathways of Vulnerability
-
批准号:8425163
-
项目类别:
-
资助金额:$117.29万
-
财政年份:2004
-
负责人:WILLIAM MAIXNER
-
依托单位:
CNS Processes Underlying Pain Regulation and Persistence
-
批准号:6951194
-
项目类别:
-
资助金额:$124.47万
-
财政年份:2004
-
负责人:WILLIAM MAIXNER
-
依托单位:
CNS Processes Underlying Pain Regulation and Persistence
-
批准号:7112908
-
项目类别:
-
资助金额:$123.56万
-
财政年份:2004
-
负责人:WILLIAM MAIXNER
-
依托单位:
Administrative Core
-
批准号:8457075
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2004
-
负责人:WILLIAM MAIXNER
-
依托单位:
Complex Persistant Pain Conditions: Unique & Shared Pathways of Vulnerability
-
批准号:8457063
-
项目类别:
-
资助金额:$129.73万
-
财政年份:2004
-
负责人:WILLIAM MAIXNER
-
依托单位:
Complex Persistent Pain Conditions: Unique & Shared Pathways of Vulnerability
-
批准号:8273089
-
项目类别:
-
资助金额:$20.37万
-
财政年份:2004
-
负责人:WILLIAM MAIXNER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: